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METHODOLOGY Open Access
A statistical framework for quantifying clinical
equipoise for individual cases during randomized
controlled surgical trials
Nicholas R Parsons1*, Yuri Kulikov1, Alan Girling2 and Damian Griffin1
Abstract
Background: Randomised controlled trials are being increasingly used to evaluate new surgical interventions.
There are a number of problematic methodological issues specific to surgical trials, the most important being
identifying whether patients are eligible for recruitment into the trial. This is in part due to the diversity in practice
patterns across institutions and the enormous range of available interventions that often leads to a low level of
agreement between clinicians about both the value and the appropriate choice of intervention. We argue that a
clinician should offer patients the option of recruitment into a trial, even if the clinician is not individually in a
position of equipoise, if there is collective (clinical) equipoise amongst the wider clinical community about the
effectiveness of a proposed intervention (the clinical equipoise principle). We show how this process can work
using data collected from an ongoing trial of a surgical intervention.
Results: We describe a statistical framework for the assessment of uncertainty prior to patient recruitment to a
clinical trial using a panel of expert clinical assessors and techniques for eliciting, pooling and modelling of expert
opinions. The methodology is illustrated using example data from the UK Heel Fracture Trial. The statistical
modelling provided results that were clear and simple to present to clinicians and showed how decisions
regarding recruitment were influenced by both the collective opinion of the expert panel and the type of decision
rule selected.
Conclusions: The statistical framework presented has potential to identify eligible patients and assist in the
simplification of eligibility criteria which might encourage greater participation in clinical trials evaluating surgical
interventions.
Keywords: Equipoise, Randomised controlled trial, Surgery, Statistical model
1 Background
There is an increasing demand for randomised con-
trolled trials (RCTs) in surgery to provide high quality
evaluation of new interventions; we use the word inter-
vention synonymously with treatment, procedure or sur-
gical procedure. In a background of ever evolving and
improving healthcare, differences between interventions
for the same condition are often small, substantially
increasing the risk of biased estimation of treatment
effects in simple (uncontrolled) observational studies of
the interventions [1]. The need for the kind of high
level evidence provided by RCTs for surgical interven-
tions is clear [2], although a number of methodological
issues have been raised for surgical trials [1,3]. One of
the most important issues being recruitment, and speci-
fically identifying whether patients are eligible for entry
into a trial.
The existing tremendous diversity in practice patterns
across institutions coupled with an ever increasing range
of available interventions suggests a low level of agree-
ment between clinicians about both the value of many
interventions and the appropriate choice of intervention
[4]. A present or imminent controversy in the expert
medical community about a choice between interven-
tions is called clinical (or collective) equipoise. Equipoise
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is the point where we are equally poised in our beliefs
about the potential benefits of a particular intervention
[5]; i.e. is intervention A better than intervention B.
Clinical equipoise is present “if there is genuine uncer-
tainty within the expert medical community - not neces-
sarily on the part of the individual investigator - about
the preferred treatment” [5]. In many cases the only way
to resolve collective uncertainty about the optimum
intervention choice is to undertake a clinical trial. Indi-
vidual equipoise relates to a single clinician, i.e. the posi-
tion where he or she has no preference amongst a range
of available treatments. It is subject to change for a host
of reasons, including peer pressure, the results of poten-
tially imperfect studies and the influence of advertising.
Freedman [5] argues that global clinical equipoise
should override the individual clinician’s lack of equi-
poise. Clinicians should subsume their personal views
and recruit patients into a trial, even if not individually
in a position of equipoise themselves. This view is impli-
citly accepted by society in the form of ethics commit-
tees, which must ensure that the treatments being
compared are reasonable options before trial partici-
pants are sought. Often, for a treatment that is not com-
pletely novel, this is demonstrated by the presence of
clinical equipoise in an expert and/or wider medical
community. Once ethics committee permission has been
granted, it then becomes an individual clinician’s deci-
sion whether the offer of entry into the trial is appropri-
ate for an individual patient [6]. Unfortunately, the
varied preferences expressed (which may be rational,
anecdotal or irrational) between individual institutions
and between individual surgeons within and between
institutions often make patient recruitment to trials very
challenging.
Statistically the level of individual uncertainty about
the effectiveness of an intervention can be quantified by
a (subjective) probability, which is assigned to a specific
hypothesis and is personal and varies with an indivi-
dual’s knowledge and expertise. “A measure of a state of
knowledge” [7] is provided by the Bayesian concept of
subjective probability. The process of expert evaluation
about the effectiveness of a proposed intervention in an
RCT is synonymous with elicitation of a Bayesian prior;
i.e. a statement of knowledge prior to performing an
experiment or trial usually stated in the form of a prob-
ability density. There are a number of approaches to
turning informally expressed ideas into a mathematical
prior distribution, with no consensus as to the optimal
method of determination for a process that is usually
problem specific [8]. We choose to elicit the subjective
opinion of a panel of experts as a basis for decision
making regarding the eligibility of a patient for recruit-
ment to an RCT [9]. This has the advantage of being
dynamic and flexible, in the sense that it is quite feasible
that opinions will change during the course of a trial, for
example with the publication of related research [8], or
as experience accumulates amongst clinicians as to how
best to undertake a surgical procedure.
Methods for formal measurement of clinical uncer-
tainty, as a prelude to a clinical trial have been sug-
gested previously [10] and measures of surgeon’s
equipoise in the setting of surgical trials have also been
reported [11]. However, we develop these ideas further,
using techniques for eliciting subjective judgements
before a trial [12-14] and introduce a novel framework
for decision making regarding recruitment to an RCT
that we hope will be easily understood by clinicians and
implemented in real time during the course of a trial. It
is particularly challenging recruiting patients to trials
comparing operative to non-operative treatments or a
standard against a new but popular well-marketed treat-
ment. Therefore we develop a statistical framework to
model clinical equipoise (Section 3), using a parametric
and a nonparametric approach, for data collected from a
clinical trial comparing conservative and operative treat-
ment for displaced fractures of the calcaneus. The
results of applying the models are reported in Sections
3.7-10 and we draw conclusions in Section 4.
2 Methods
Using available web design tools a method was devel-
oped to capture the opinions of clinicians in real time
for individual patients (cases) in an ongoing RCT. It
comprised of a virtual expert panel giving their opinion
about the effectiveness of a proposed treatment for indi-
vidual patients based on online clinical details; the indi-
vidual assessments were then synthesized and fed back
electronically to the lead clinical investigator. This pro-
cess is described in greater detail below.
Patients who met the initial trial inclusion criteria
were identified and approached by a member of the
research team to alert them to the possibility of partici-
pating in a trial. They were then asked permission for
their anonymized clinical details to be distributed
among a panel of experts/clinicians for an opinion
regarding the effectiveness of the proposed treatment.
Clinical data from consented patients were made avail-
able on a secure website managed by eLab at the Uni-
versity of Warwick, and all panel experts/clinicians were
alerted by email and text message (if requested) to the
posting of a new patient and asked to offer their perso-
nal opinion on the likely success of the proposed treat-
ments. The assessment scale is described in more detail
for the specific example of the UK Heel Fracture Trial.
Initially the system was tested in a pilot study with
seven surgeons from five UK hospitals. Ten retrospec-
tive calcaneal fracture cases were selected to represent
typical variability. The surgeons followed the
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instructions on the website with online and telephone
technical support available; no specific training was
given. When voting on all ten cases was completed, sur-
geons were asked to fill in an evaluation questionnaire.
Voting on a single case never took longer than 5 min-
utes and the available clinical information was found
sufficient and the whole process user friendly by all par-
ticipating surgeons.
After the successful pilot study the system was intro-
duced as an independent component of the UK Heel
Fracture Trial, which compared conservative and opera-
tive treatment for displaced fractures of the calcaneus.
The study had separate ethical approval and a consent
form, in addition to the main trial. This allowed inclu-
sion both of those patients who took part in the UK
Heel Fracture Trial and those who declined, as soon as
the patient met the trial eligibility criteria. To avoid
interference with the clinical course, patients were asked
permission to use their data at the 6 weeks follow-up
clinic or later. Their anonymous clinical data including
X-rays and CT images were posted to a secure website.
The expert assessment panel included 12 surgeons from
9 hospitals. All surgeons were foot and ankle specialists
and acted as principal investigators in their individual
trial centres.
After assessing the clinical data available for a given
patient, the surgeon was able to scroll down to an inter-
active scale, featuring bars (initially set at zero) above
each of seven outcome categories indicating whether
after surgical intervention the patient would get “much
worse“ (1), “significantly worse“ (2), “a bit worse“ (3), “no
difference“ (4), “a bit better“ (5), “significantly better“ (6)
or “much better“ (7). A left-click of the mouse and a
drag allowed each outcome prognosis bar to be set to a
desired percentage, which was reported numerically over
the bar. Once the assessment summed to 100%
(reflected in a digital window in the upper left corner of
the scale) the submit button allowed the data to be sent
to the trial lead for analysis. The UK Heel Fracture Trial
compared operative (surgical) and non-operative (con-
servative) treatment. Surgical techniques are becoming
widespread for calcaneal fracture, but do have associated
risks, therefore it was important for the clinician to
assess the improvement potential relative to the risks for
this procedure. Belief, in the context we describe here,
that surgery can make a patient better implies intention
to do surgery, while disbelief implies intention to avoid
surgical intervention, hence to choose the conservative
option. The question posed to the expert panel can and
should be tailored to the specific trial. For the UK Heel
Fracture Trial the experts were asked to compare opera-
tive (surgical) and non-operative (conservative) treat-
ment, which although strongly contrasting treatment
options may vary in the exact detail of the constituent
components. For studies with less contrasting treatment
options (e.g. two types of surgery) the question to
experts may simply be whether the test intervention
would be better or worse for a patient, compared to a
control (standard) intervention.
Table 1 shows four examples of data elicited from
between 4 and 6 clinical experts, not necessarily the
same individuals labelled as 1 to 6, who provided their
opinions on the effectiveness of surgical compared to
non-surgical intervention after fracture of the calcaneus.
As expected there are clear differences in the both the
locations and shapes of the individual distributions for a
number of these cases and indeed a number of clear
similarities for other cases. For instance, the opinions of
the clinicians vary widely for case 1; clinical expert 3 is
reasonably confident that the patient will improve signif-
icantly after treatment whereas for expert 4 the most
likely outcome of treatment is that the condition of the
patient will be unchanged. There is much clearer
Table 1 Assessment of the likely effectiveness of surgical
intervention after fracture of the calcaneus for four
example cases and up to six clinical experts
Case Assessment Clinical Expert
1 2 3 4 5 6
Case 1 Much Worse 5 5 0 0 0 0
Significantly Worse 5 5 0 0 5 9
A Bit Worse 10 25 5 15 10 21
No Difference 20 50 5 59 30 36
A Bit Better 30 15 15 25 45 23
Significantly Better 20 0 70 1 10 11
Much Better 10 0 5 0 0 0
Case 2 Much Worse 0 0 0 0 0 -
Significantly Worse 0 0 2 0 0 -
A Bit Worse 10 0 4 10 5 -
No Difference 15 10 12 13 20 -
A Bit Better 40 40 32 35 45 -
Significantly Better 30 50 48 40 30 -
Much Better 5 0 2 2 0 -
Case 3 Much Worse 10 10 5 5 - -
Significantly Worse 10 20 10 15 - -
A Bit Worse 15 30 10 20 - -
No Difference 20 20 15 20 - -
A Bit Better 20 10 30 20 - -
Significantly Better 15 10 20 15 - -
Much Better 10 0 10 5 - -
Case 4 Much Worse 20 5 40 10 20 -
Significantly Worse 60 85 50 80 70 -
A Bit Worse 15 10 10 5 5 -
No Difference 5 0 0 5 5 -
A Bit Better 0 0 0 0 0 -
Significantly Better 0 0 0 0 0 -
Much Better 0 0 0 0 0 -
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agreement for case 4 where all the experts expect the
patient to worsen significantly after treatment. How do
we use these data to decide whether a patient (case) is
eligible for recruitment to a clinical trial? We propose
two approaches here to model the opinions obtained
from each expert clinician, a parametric model based on
a Beta distribution (Section 3.2) and a nonparametric
model based on estimated means and standard devia-
tions (Section 3.3) that characterise expert opinions
using concepts of belief, disbelief and uncertainty. The
belief, disbelief and uncertainty are visualized using a
ternary plot that displays these characteristics in a man-
ner that allows them to be compared to decision rules
that partition the opinion space. Finally, resampling
methods are used to draw inferences concerning the
sufficiency of evidence from the clinical experts to
patient eligibility for recruitment
3 Results and Discussion
3.1 Expert opinion
An opinion regarding the effectiveness of a procedure
can be thought of as comprising of three distinctive
aspects; belief, disbelief and uncertainty. Belief represents
the tendency of an expert to expect a particular treat-
ment to perform better than an alternative (control
intervention) for a particular patient (case); i.e. the ten-
dency for the experts to score cases in the higher end
categories of the rating scale of Table 1. Conversely, the
level of disbelief is equated with the tendency for an
intervention to have a worse outcome as compared to a
control intervention; i.e. the tendency for the experts to
score cases in the lower end categories of the rating
scale. The uncertainty associated with the belief and dis-
belief represents the spread of the data across the opi-
nion range; i.e. all the scores might be concentrated in
the central category (no difference) or be spread equally
between all categories in Table 1 - we would have equal
belief in these two scenarios but a maximum difference
in uncertainty.
Borrowing from the notation of subjective logic
[15,16], we label the belief, disbelief and uncertainty
associated with an opinion for expert i as bi, di and ui,
and apply the constraint that
bi + di + ui = 1 and {bi, di, ui} ∈ [0, 1]3 (1)
where the triplet πi = {bi, di, ui} is described as the
opinion of expert i. Intuitively it makes sense that there
should be a constraint on these characteristics, as
expressed in (1), as clearly when we have a maximum
level of belief in a procedure we must necessarily have
zero disbelief and uncertainty. Similarly, when there is a
maximum level of uncertainty there clearly must be
zero levels of belief and disbelief. The constraint that
our levels of belief, disbelief and uncertainty must sum
to unity is of course a matter of convenience, in an ana-
logous manner to that in conventional probability where
the same constraint is used. It seems reasonable, using
statistical arguments, that we should scale our levels of
belief and disbelief about the effectiveness of a proce-
dure by the associated uncertainty. That is we are inter-
ested in the quantities b/u and d/u, in the same way we
might want to normalize a treatment difference in an
RCT by the associated standard deviation measuring the
spread or uncertainty in the estimated difference to give
an effect size. In order to estimate b, d and u, we need
to develop a model for the clinical expert assessment
data.
3.2 Parametric model
3.2.1 Assessment pooling
The assessment of the likely effectiveness of the inter-
vention x was scored on a discrete valued symmetric
scale with descriptive terms selected to imply an even
spacing between categories. For our selected example,
the seven-category ordinal scale, described in Section 2,
was transformed onto the interval [0,1] as follows;
2 → 314 , 2 → 314 , 3 → 514 , 4 → 714 , 5 → 914 , 6 → 1114
and 7 → 1314 . This retains the implicit spacing of the
ordinal scale and centres the new scale at the same
point as the original scale. Equivalent arguments can be
constructed for ordinal scales with different numbers of
categories.
Let xi, where 0 ≤ xi ≤1, quantify the likely effectiveness
of a procedure for individual expert i as part of a panel
of n experts. The distribution of xi is assumed to follow
an approximate Beta distribution (Figure 1), a continu-
ous probability distribution defined on the interval (0,1)
and parameterized by two positive parameters, denoted
by a and b, that modify the shape of the distribution.
The Beta distribution is widely used for modelling ran-
dom probabilities, particularly in the context of Bayesian
analysis [17] and has been used to describe not only
variability within a population as in a conventional sta-
tistical model, but also to describe the subjective degree
of belief in a Bayesian sense [8]. Expressed mathemati-
cally, the probability density function for xi is
fi(xi;αi,βi) =
(αi + βi)
(αi)(βi)
xiαi−1(1 − xi)βi−1, ,
where Γ(.) is the gamma function and parameters ai ≥
1 and bi ≥ 1, requiring that the distribution be unimodal
or at the extreme case, when ai = bI = 1, uniform. In
the surgical trial setting described here, it seems unlikely
that for instance a u-shaped distribution for xi (e.g. a =
0.5 and b = 0.5) would be plausible.
The multiplicative pooled assessment [18,19] of the
expert panel is obtained as
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f0(x) = {
∏n
i=1
fi(xi;αi,βi)}1/n
where f0(x) follows a Beta distribution with parameters
α¯ = 1n
∑n
i=1
αi and β¯ = 1n
∑n
i=1
βi . This provides a
pooled assessment that represents the intersection of
the beliefs of the expert panel [19].
3.2.2 Opinion model
In order to translate the assessments from the panel of
n experts to a collective expert opinion, the measures
b¯
/
u¯ and d¯
/
u¯ (Section 3.1), that characterise the
pooled opinion, are related to the pooled assessment
parameters α¯ and β¯ . Equating the level of belief
expressed by an expert to the pooled assessments, it is
clear that α¯ must be proportional to b¯
/
u¯ , that is a lar-
ger value of α¯ represents a greater degree of belief; at
the extreme as α¯ → ∞ , then b¯ → 1 and u¯ → 0 , when
we have maximum belief we must have minimum uncer-
tainty. Similarly arguments lead to β¯ being
proportional to d¯
/
u¯ ; a larger value of β¯ represents a
greater degree of disbelief. Although, clearly from exam-
ple (a) in Figure 1, when the pooled Beta distribution
parameter estimates are at their minimum and α¯ = 1
and β¯ = 1 then there is maximum uncertainty ( u¯ = 1)
and minimum belief and disbelief, b¯ = d¯ = 0 . Formalizing
these arguments leads to the following expressions that
satisfy all these conditions
b¯
u¯
= α¯ − 1 and d¯
u¯
= β¯ − 1. (2 3)
Solving equations (2) and (3), along with the condition
that b¯ + d¯ + u¯ = 1 (equation 1), yields the following
expressions that characterize the relationship between
the triplet {b¯, d¯, u¯} and the parameters α¯ and β¯ ,
b¯ =
α¯ − 1
α¯ + β¯ − 1 , d¯ =
β¯ − 1
α¯ + β¯ − 1 , and u¯ =
1
α¯ + β¯ − 1 ; (4 6)
Figure 1 Beta distributions B(a, b) for various values of parameters a and b.
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where the triplet {b¯, d¯, u¯} clearly satisfies b¯ + d¯ + u¯ = 1 ;
a more detailed derivation of equations (4)-(6) is pro-
vided elsewhere [15,16]. Thus, when α¯ = β¯ = 1 ,
π¯ = {0, 0, 1} and the pooled opinion is total uncertainty
(ignorance); see example (a) in Figure 1. If parameters
α¯ and β¯ are greater than unity but equal, we have
equal belief and disbelief; for example (b) in Figure 1
where α¯ = β¯ = 2 and π¯ = { 13 , 13 , 13 } . As α¯ increases rela-
tive to β¯ the belief increases and the uncertainty
decreases and conversely as β¯ increases relative to α¯
the disbelief increases and the uncertainty decreases;
these two scenarios are illustrated in examples (d) and
(c) in Figure 1, where α¯ = 5 , β¯ = 2 and π¯ = { 46 , 16 , 16 }
and α¯ = 2 , β¯ = 5 and π¯ = { 16 , 46 , 16 } .
3.3 Nonparametric model
An alternative nonparametric formulation for belief, dis-
belief and uncertainty allows a more general approach
to that described in Section 3.2. Defining μi and si as
the mean and standard deviation of the assessment of
the effectiveness of the intervention xi for expert i,
where xi is in the range [0,1]. Then the uncertainty (ui),
belief (bi) and disbelief (di) associated with an opinion
for expert i can be expressed as ui = σ 2i
/
μi(1 − μi) , bi
= μi(1-ui) and bi = di =(1-μi)(1-ui); as 0 ≤ xi ≤ 1, then 0
≤ ui ≤ 1 and the measures satisfy equation (1). For
example using the data from Table 1 for expert 4 from
case 3, the weighted mean and standard deviation, based
on the transformed seven-category ordinal scale
described in Section 3.2.1
(1/14, 3/14, 5/14, 7/14, 9/14, 11/14, 13/14) with weights given by
(5,15,20,20,20,15,5), are μ = 0.5 and s = 0.226, and so u
= 0.204 and b = d = 0.398. Multiplicative pooling leads
directly to estimates for the opinion triplet {b¯, d¯, u¯} ,
with weights given by the nth root of the product of the
individual expert weights, in an analogous manner to
that described in Section 3.2.1 for the parametric model.
In fact the expressions for uncertainty, belief and dis-
belief for the Beta model in equations (4)-(6) follow
directly from the above expressions for u, b and d,
based on μ and s, after some rescaling, by noting that
the mean and variance of the Beta distribution are a/(a
+b) and ab/{(a+b)2 (a+b+1)} respectively.
3.4 Opinion space
As proposed by Jøsang [15], a ternary plot provides a
convenient method of representing the triplet of belief,
disbelief and uncertainty that constitute a pooled expert
opinion. A ternary plot represents the ratios of the three
variables as positions in an equilateral triangle, where
each base, or side, of the triangle represents a propor-
tion, with the point of the triangle opposite that base
representing a proportion equal to one. As a proportion
increases in any one sample, the point representing that
sample moves from the base to the opposite point of
the triangle. For instance, when α¯ = β¯ = 1 (maximum
uncertainty) the opinion is mapped to the apex of the
equilateral triangle, whereas when α¯ = β¯ = 2 there is
equal belief, disbelief and uncertainty and the pooled
opinion is mapped to the centre of the triangle. The
cases representing greater levels of belief and greater
levels of disbelief are mapped towards the right-hand
and left-hand vertices of the triangle respectively.
3.5 Decision rules
In order to determine the level of equipoise that should
be satisfied for a clinical trial to be considered ethical
Johnson et al. [20] conducted an ethometric study to
investigate how much clinical equipoise can be dis-
turbed before potential trial subjects deem it to be
unethical. A series of hypothetical clinical trial scenarios
were presented to people from a broad range of societal
and geographical groups within the UK. They were
asked to specify the level of collective doubt between
two treatment modalities that they would accept if cast-
ing a vote on an ethics committee. Johnson et al. [20]
defined the 80:20 rule, that represented the split in equi-
poise that should be allowed for a trial to be judged to
be ethical and recommended its use as an appropriate
tool for deciding whether recruitment is ethically justifi-
able; based on their empirical evidence that less than 3%
of subjects questioned thought that a trial should
morally be undertaken if equipoise was beyond this
point. By way of comparison, an alternative mean
threshold rule might consider it ethical to recruit
patients if the mean clinical effectiveness (μ), estimated
as a/(a+b) for the Beta distribution, were within pre-
determined limits. For instance, it might be considered
ethical to recruit patients into a trial if the mean clinical
effectiveness were in the range 0.4 ≤ μ ≤ 0.7.
The 80:20 and mean threshold equipoise decision rules
can be mapped onto the opinion space and visualized
on a ternary plot. For the Beta model (Section 3.2), the
former rule can be mapped on to the ternary plot by
iteratively finding solutions for Beta distribution para-
meters, a and b, that give estimates for the probability
density function equal to 0.2 and 0.8 to the left and
right of the central point on the expert rating scale, and
for the latter rule by simply solving equations (4)-(6)
using the constraint that μ(a+b)=a.
Parsons et al. Trials 2011, 12:258
http://www.trialsjournal.com/content/12/1/258
Page 6 of 11
3.6 Hypothesis testing
The significance of the estimated pooled opinion ( π¯ ) is
assessed using resampling. For the Beta model for Sec-
tion 3.2, pooled assessment parameters
α¯∗m =
1
n
∑
i∗∈Sm
αi∗ and β¯
∗
m =
1
n
∑
i∗∈Sm
βi∗ are estimated
for Sm, a set of size n constructed by sampling with
replacement from {1,2...n}; for example for the pooled
assessment of 5 experts Sm might be {1,2,2,4,1} or
{5,3,3,1,1}. This process is repeated many times by ran-
dom construction of Sm to give empirical bootstrap [21]
distributions α¯∗1, α¯
∗
2, . . . , α¯
∗
M and β¯
∗
1, β¯
∗
2, . . . , β¯
∗
M , and
thereby π¯∗1 , π¯
∗
2 , . . . , π¯
∗
M . From this empirical distribu-
tion, a bootstrap confidence interval for π¯ is derived for
the purpose of hypothesis testing. A similar resampling
scheme can also be developed simply for the nonpara-
metric model of Section 3.3.
This resampling methodology represents the variability
in opinion that might be obtained for any combination
of experts in the panel, including in principle a panel
composed entirely of a single expert, and as such repre-
sents the full range of possible opinions for the selected
population of experts. For the relative small panel of
experts in our example, exhaustive permutation resam-
pling [21] is the preferred option, but this may be com-
putational unrealistic for large n where bootstrapping
with M = 1000 would be sufficient.
3.7 Beta distribution fitting
The outlined statistical framework is illustrated using
the example data introduced in Section 2 (Table 1). We
focus here on the Beta model (Section 3.2) as an exem-
plar, as this fits our data well and is computational
slightly more complex to implement than the nonpara-
metric method. Statistical analysis was undertaken in
the statistical software package R [22]. Code to replicate
the analysis presented here is available on request from
the corresponding author.
The parameters of the Beta distribution were esti-
mated for each clinical expert for the four cases shown
in Table 1 using the fitdistr function available in
the MASS [23] library in the statistical software pack-
age R [22]. This function estimates parameters for a
range of univariate distributions, including the Beta
distribution, using maximum-likelihood methods. For
the four example cases introduced in Section 2 the
pooled parameter estimates were α¯1 = 7.11 , α¯2 = 9.57,
α¯4 = 5.14, α¯4 = 5.14 and β¯1 = 5.67, β¯2 = 4.71 ,
β¯4 = 19.01 , β¯4 = 19.01 . The fitted distributions for
each clinical expert and pooled estimates are shown in
Figure 2.
3.8 Opinions
The pooled parameter estimates from the Beta distribu-
tion fitting for the four example cases were used to esti-
mates the belief, disbelief and uncertainty using
equations (4)-(6); this gave the following estimates,
b¯2 = 0.645, b¯2 = 0.645, b¯3 = 0.307, b¯4 = 0.179,
d¯2 = 0.279 , d¯2 = 0.279 , d¯3 = 0.341 , d¯4 = 0.778 and
u¯2 = 0.075, u¯2 = 0.075, u¯3 = 0.351 , u¯4 = 0.043 . Inspec-
tion of Figure 2, indicates that there appears to be sig-
nificant belief for case 2 that the patient will improve
after treatment (surgery) and conversely significant dis-
belief in the effectiveness of the treatment for case for
case 4; this is reflected in the large (> 0.6) estimates of b
and d for cases 2 and 4 respectively. Also, there is sig-
nificant uncertainty, seen by the flatness of the curves in
Figure 2(c), in the collective opinions of the experts for
case 3; this is apparent in the large level of uncertainty
for this case, relative to the other cases.
3.9 Decision rules
In order to determine whether an opinion provides suf-
ficient evidence for eligibility for recruitment to a clini-
cal trial, we must first define a decision rule. Here we
focus on two rules, the 80:20 [20] and the mean thresh-
old rules; although the procedures described here are
equally applicable to many more rules that could poten-
tially be defined. The 80:20 and mean threshold rules
partition the opinion space, visualized by the ternary
plot, into regions that determine whether the patient
can or cannot ethically be recruited to a trial.
The division lines between the regions for the 80:20
rule were determined iteratively (using an interval
search method) by finding estimates of the Beta distri-
bution parameters a and b that exactly divided the
probability density 80% and 20% around equipoise, and
projecting these estimates into the opinion space using
equations (4)-(6). This process was achieved using an
implementation of the uniroot function in R [22].
After discussion with the clinical experts it became clear
that the point of equipoise for the assessment scale
described in Section 2 for the 80:20 rule was not located
centrally but was in fact located at the division between
the ‘No difference’ and the ‘A bit better’ categories. That
is, because surgery was seen to be an active intervention
for a condition that required treatment, the point of
equipoise was located slightly to the right of the centre
point of the assessment scale; which for our definition
of the assessment scale is at 8/14 rather than at 1/2 on
the interval (0, 1). The asymmetry that this implies for
the 80:20 decision rule is clear in Figure 3. The mean
threshold rule divided the opinion space into three
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distinct regions μ < 0.4, 0.4 ≤ μ ≤ 0.7 and μ < 0.7 char-
acterised by the thresholds 0.4 and 0.7 for the mean,
that determined whether the intervention was likely to
be effective. The divisions between regions were mapped
onto the opinion space by solving equations (4)-(6)
using the constraint that μ(a+b) = a. For instance for μ
= 0.7 and u = 0, then b = 0.7 and d = 0.3 and when d =
0 then u = 3/7 and u = 4/7 ; these points define the
intersections between the upper division boundary with
the lower and right edges of the ternary plot in Figure 3.
3.10 Hypothesis testing
The exhaustive permutation test described in Section 3.6
was applied to each of the test cases. This gave 462, 126,
35 and 126 combinations of opinions for the four cases
that used respectively 6, 5, 4 and 5 expert clinical asses-
sors. The belief, disbelief and uncertainty for all the
Figure 2 Fitted Beta distributions for each clinical expert (—) and pooled estimates (-) for each case.
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combinations of opinion were estimated for each of the
four cases and plotted along with the decision rules in
Figure 3.
The ‘cloud’ of points for each case represents the
variability due to the range of opinions expressed by the
expert assessors. Where there were considerable differ-
ences of opinion, for instance for case 1, there was a
much wider spread of points than where there was over-
all agreement amongst the experts about the likelihood
of success of the intervention, for instance for case 2 or
4. It is instructive to look at one particular opinion tri-
plet to more fully understand the meaning of the tern-
ary plots.
For case 1, the opinion triplet π = {0.712,0.211,0.077}
located towards the lower right hand vertex of the tern-
ary plot has very high belief and low uncertainty. This is
the opinion associated with six replicates of the assess-
ment of clinical expert 3 for case 1 (see Table 1), who
had a strong belief that the patient would get signifi-
cantly better after treatment. If this expert assessor were
Figure 3 Estimated triplets for all permutations of opinions with the 80:20 (—) and mean (–) decision rules. The best estimate of
collective opinion is given by the large symbol (•).
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indeed representative of the wider population of experts,
then it would certainly be unethical for the patient to be
recruited to the trial and consequentially the opinion for
this potential scenario is located to the right of the
80:20 and mean threshold decision rules.
Labelling the regions to the lower right and lower left
of the plots to the right and left of the 80:20 and mean
threshold decision rule partition curves as the ‘belief’
and ‘disbelief’ regions, allows us to count the number of
opinions falling within these regions for each case and
rule; see Table 2. Defining the null hypothesis to be that
a case should not be recruited to the trial, Table 2 pro-
vides evidence for this hypothesis and suggests appropri-
ate p-values based on the 80:20 rule for the four cases to
be 0.026 (i.e. 12/462), 0.333, 0.000 and 1.000 and based
on the mean threshold rule to be 0.011 (i.e. 5/462),
0.000, 0.029 and 1.000. Testing at the 5% level (two-
sided) indicates that for the 80:20 rule cases 1 and 3
would be eligible for recruitment and for the mean
threshold rule cases 1, 2 and 3 would be eligible for
recruitment. For this decision making process to have
some validity, the decision rule and the significance
level would clearly need to be stated before data collec-
tion was undertaken.
4 Conclusions
We describe a statistical framework for the assessment
of clinical uncertainty, as a prelude to a clinical trial and
demonstrate, using data from the UK Heel Fracture
Trial, how expert opinions can be pooled, modelled and
presented on a ternary plot that represents an opinion
space. Individual cases can then be assessed in relation
to decision rules mapped onto the opinion space, pro-
viding clear and rapid decisions regarding trial eligibility.
The methodology has potential to identify eligible
patients and assist in the simplification of eligibility cri-
teria which might encourage greater participation in
clinical trials.
Methods for the assessment of clinical uncertainty, as
a prelude to a clinical trial, have been suggested pre-
viously [10,11]. However, the methodology described
here is the first attempt at a structured statistical frame-
work to undertake this type of analysis. Beta
distributions were fitted to assessments of the likely
effectiveness of an intervention elicited from a virtual
panel of experts and pooled using methods familiar to
exponents of determining expert probabilities [19]. Opi-
nions were expressed using previously suggested [15]
definitions of belief, disbelief and uncertainty that we
believe fully characterised the clinical expert assess-
ments. Our analysis restricted the choice of Beta distri-
butions for modelling to unimodal forms (a ≥ 1 and b ≥
1). This was not a concern for the examples described
here or indeed more widely for other data we have
explored in the setting of surgical trials. However, it is
in principle possible in other applications that the most
likely assessment of clinical effectiveness of an interven-
tion is that a patient would either get much better or
much worse with any other outcome being extremely
unlikely. In this setting belief, disbelief and uncertainty
as expressed in equations (4)-(6) would not be defined.
For the data presented here the Beta model proved to
be the most informative, however where this is not the
case the nonparametric methods described, based on
estimated means and standard deviations, provide useful
alternatives for any distribution on the interval [0,1].
Although the examples described here all use seven
point likert type scales for elicitation, the statistical fra-
mework introduced would work equally well with any
type of ordered categorical assessment scale.
Expert opinions are pooled here using multiplicative
methods [19], as we felt that this best represented clini-
cal equipoise [24] and the views of the experts consulted
for the example data; i.e. that all experts opinions were
‘correct’ and the pooling should represent the consensus
based on the intersection of beliefs. However, our view
is pragmatic and we see no reason why additive pooling
could not be used in preference to multiplicative pool-
ing, particularly if it was felt that the latter method was
giving too much weight to the assessment of one or
more ‘over-confident’ individual experts.
We have presented significance tests at the 5% level to
assess whether a patient might ethically be recruited to
a trial. Our selection of this level for the tests was some-
what arbitrary and clearly this could be set, prior to ana-
lysis, at a higher or lower level for a different application
or a less formal procedure adopted if necessary. The
80:20 rule [20], which is based on some empirical evi-
dence, was selected as a standard for decision making
regarding recruitment. The alternative mean threshold
rule, as well as being intuitively reasonable, was sug-
gested in part to encourage some debate as to what
form the decision rule should take for different cases
and in various settings. This is clearly an area that
requires additional research.
The focus of this paper has been on developing tools
for improving recruitment to trials. For those patients
Table 2 Opinion counts by case, decision region and rule,
and the total number of opinion combinations available
for the exhaustive permutation test
Rule Region Case 1 Case 2 Case 3 Case 4
80:20 Belief 12 42 0 0
Disbelief 0 0 0 126
Mean threshold Belief 5 0 0 0
Disbelief 0 0 1 126
Opinion Combinations 462 126 35 126
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deemed eligible for recruitment who decide to enter an
RCT, it would seem natural to use the expert evidence
elicited through this process as a clinical prior, based on
subjective opinion, in a formal Bayesian analysis [14].
The methodological framework discussed here has
provided additional insight that would otherwise have
not been available for the heel fracture trial. Although,
clearly this methodology will need to be assessed in
future studies to identify whether it can actually deliver
improvement in trial recruitment rates. The methodolo-
gical framework we describe is currently limited to two-
arm trials, although we see no reason why this could
not be extended to more than two treatment groups.
The opinion pooling we describe is appropriate for
situations where individual expert opinions may differ to
a moderate or large extent, but it is not at all clear that
pooling opinions where for instance experts have totally
opposing views (100% belief or disbelief in treatment
effectiveness) would be appropriate, as the pooled opi-
nion would in reality represent no individual expert’s
opinion. Therefore we would recommend the methodol-
ogy be limited to only those scenarios of the former
rather than the latter type. Although we have focussed
on surgical trials, we would expect the methodology
described here to be applicable to any RCT where
recruitment was problematic. The methodology also has
clear application in pilot studies where feasibility is
being assessed and also potentially as a support tool for
inclusive trials where patients are allowed to select an
intervention as well as being randomised in a conven-
tional manner [25].
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